Chris B. Russell

5.0k citations
39 papers · 3.7k indexed · 4 hit papers · h-index 24
Topics
Psoriasis: Treatment and Pathogenesis (8 papers)Dermatology and Skin Diseases (7 papers)Asthma and respiratory diseases (7 papers)

In The Last Decade

Chris B. Russell

38 papers receiving 3.7k citations

Hit Papers

Brodalumab, an Anti–Interleukin-17–Receptor Antibody for ...20122026201620212012201620202016200400600

Peers

Chris B. Russell
Comparison fields: 5 of 114
  • Immunology 2.3k
  • Dermatology 1.1k
  • Molecular Biology 904
  • Genetics 604
  • Physiology 584
Replace Francesca Capon with:
Francesca Capon United Kingdom
Athanasia D. Panopoulos United States
Renu Jain United States
Bhanu P. Pappu United States
Kristine Kikly United States
Carlo Pucillo Italy
Jane R. Parnes United States
Francescopaolo Granata Italy
Masakatsu Yamashita Japan
Chris B. Russell relative to Francesca Capon United Kingdom Francesca Capon's profile →
Citations per field
00.5×1.5×1.8×
Francesca Capon · 1×
Citations per year

Countries citing papers authored by Chris B. Russell

Since Specialization
Citations

This map shows the geographic impact of Chris B. Russell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris B. Russell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris B. Russell more than expected).

Fields of papers citing papers by Chris B. Russell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chris B. Russell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris B. Russell. The network helps show where Chris B. Russell may publish in the future.

Co-authorship network of co-authors of Chris B. Russell

This figure shows the co-authorship network connecting the top 25 collaborators of Chris B. Russell. A scholar is included among the top collaborators of Chris B. Russell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chris B. Russell. Chris B. Russell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 17
3 77
4 24
5 15
6 18
7 36
8 7
9
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Brodalumab in Patients With Moderate-to-Severe Crohn’s Diseasebreakdown →
289
10 42
11 58
12 386
13
Brodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasisbreakdown →
729
14 101
15 37
16 18
17 73
18 19
19 44
20 19

About Chris B. Russell

Chris B. Russell is a scholar working on Dermatology, Hematology and Immunology, having authored 39 papers that have together received 3.7k indexed citations. Recurring topics across this work include Psoriasis: Treatment and Pathogenesis (8 papers), Dermatology and Skin Diseases (7 papers) and Asthma and respiratory diseases (7 papers). The work is most often cited by research in Dermatology (1.1k citations), Immunology (2.3k citations) and Hematology (467 citations). Chris B. Russell has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include James G. Krueger, Roland Martinꝉ, Jennifer E. Towne, Gregory Kricorian, Paul Klekotka, Kim Papp, Frederick W. Dahlquist, Michelle A. Lowes, Alan Menter and Girish Aras. Their work appears in journals such as New England Journal of Medicine, Nucleic Acids Research and Nature Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026